hair loss and glp-1 has increasingly been reported among patients using GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed GLP-1, Peri-menopause and Hair Loss

What This Looks Like at Strong Republic Our semi-private training sessions focus on progressive strength training designed for adults over 40

This study implies that maintaining iron homeostasis is essential for eliminating pathogenic Tfh cells, which may lead to a more effective treatment for SLE patients

T., Vasa, R

In the United States, nine out of 10 prescriptions issued are for generic, instead of brand-name medications

L-carnitine doses range from 1 to 3 grams daily, often split into two doses

Oral Obesity Drugs Market Overview The Global Oral Obesity Drugs Market stood at US$ 4.43 billion in 2025 and is expected to reach US$ 58.91 billion by 2035 , growing with a CAGR of 27.84% during the forecast period 2026-2035